Taevas
IndiaPersonal Care & Beauty
Product Registration
Market Access for Product-Registration in India
Navigating the complex global regulatory landscape for product registration requires a strategic market access approach. Taevas Life Sciences provides comprehensive solutions to optimize your product's journey from development to commercialization across
Market
Global
Industry
Product-Registration
Regulator
Global Regulatory Authorities
Timeline
4-6 weeks (initial strategy)
Deliverables
Market Access Strategy, Regulatory Roadmap, Value Dossier
What We Deliver
6 Pillars of Market Access for Global Product Registration
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory Intelligence & Landscape Analysis
We provide in-depth analysis of diverse global regulatory frameworks, identifying critical requirements and potential barriers for your product's registration. This foundational intelligence informs all subsequent strategic decisions.
Comprehensive country-specific regulatory reviews
Identification of expedited pathways and data requirements
How It Works
How Our Global Market Access Process Works
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1
Discovery & Scope Definition
We begin with a thorough assessment of your product, target markets, and existing data. This phase clarifies objectives, identifies potential challenges, and defines the scope of our strategic engagement.
Market Snapshot
Market Overview: Global Product Registration & Market Access
Increasing Regulatory Divergence
The global regulatory landscape is becoming increasingly fragmented, with new requirements and expedited pathways emerging. Navigating these divergences requires expert strategic insight to avoid delays and maximize market potential.
Value-Based Access Demands
Payers and HTA bodies globally are demanding stronger evidence of real-world value. A robust market access strategy must integrate evidence generation from early development to post-market surveillance to secure favorable access.
Early Engagement Criticality
Proactive engagement with regulatory authorities and HTA bodies early in the development cycle can significantly de-risk product registration and accelerate market access, optimizing the commercial trajectory.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Comprehensive Global Market Access Strategy
A detailed strategic document outlining market entry pathways, regulatory requirements, HTA considerations, and optimal pricing strategies for your target markets.
Tailored Regulatory Roadmap
A step-by-step guide detailing the specific regulatory submission requirements, timelines, and necessary evidence for product registration in each chosen country.
Value Dossier & HTA Submission Support
Development of robust value dossiers and strategic support for Health Technology Assessment (HTA) submissions, articulating the clinical and economic value of your product.
Stakeholder Engagement Plan
A strategic framework for engaging key regulatory bodies, payers, clinicians, and patient groups to build support and facilitate market acceptance.
Who This Is For
Use Cases
Biotech Startup
First Global Launch of a Novel Orphan Drug
A biotech company with a breakthrough orphan drug needed to navigate simultaneous product registration and market access in the EU, US, and Japan, facing complex rare disease regulations and HTA requirements.
Outcome
Taevas developed an integrated global strategy, securing accelerated approvals and favorable reimbursement across all target markets.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Start Market Access in Global?
Partner with Taevas Life Sciences to navigate the complexities of global product registration and secure optimal market access for your innovations.
Access to Global Regulatory Expertise
Streamlined Market Entry Processes
Optimized Pricing & Reimbursement
Enhanced Commercial Success